CA
NZ
UK
AU
IND
US
Fractyl Health is pressing ahead with its most consequential clinical milestone in the company's short history. The Boston-based medical device and therapeutics company reaffirmed that topline data from its pivotal REMAIN-1 study — evaluating the Revita duodenal mucosal resurfacing system in patients seeking to …
Personalis has secured a meaningful expansion of Medicare coverage for its flagship NeXT Personal minimal residual disease assay — a development that materially widens the commercial runway for one of oncology diagnostics' most sophisticated platforms.
SELLAS Life Sciences Group stands at an inflection point. With 78 of the 80 required events now recorded in its pivotal Phase 3 REGAL trial of galinpepimut-S, the New York-based biotechnology company is days — perhaps weeks — away from a topline data readout …
Protalix BioTherapeutics has entered 2026 with meaningful commercial momentum. The Israeli-American biopharmaceutical company reaffirmed its full-year revenue guidance of $78 to $83 million following a significant label update for Elfabrio — its plant cell-expressed alfa-galactosidase A enzyme replacement therapy for Fabry disease — and …
BeyondSpring's first quarter of 2026 presents a tale of twoBalance Sheetlines. Strip away the noise from discontinued operations and the underlyingBusinessis demonstrating genuine improvement — a loss from continuing operations of just $2.4 million signals a leaner cost structure and tightening operational discipline. Add …
PMGC Holdings is executing its aerospace and defence manufacturing roll-up with disciplined speed. The company announced the acquisition of A&B Aerospace, a precision machiningBusinessserving the aerospace sector, for $4.5 million — its fifth acquisition in the past twelve months and a further concrete step …
On May 4, two announcements arrived within hours of each other. Anthropic unveiled a $1.5 billion enterprise AI venture backed by Blackstone (NYSE: BX), Goldman Sachs (NYSE: GS), Hellman and Friedman, and SequoiaCapital. Reports emerged the same day that OpenAI was raising more than …
The U.S. Senate's Clarity Act proposes the most comprehensive crypto regulatory framework to date, covering stablecoins, AML compliance, SEC exemptions, DeFi classification, and tokenisedAssets. Here is what institutional investors and crypto firms need to know before Thursday's voteKey HighlightsSenate Banking Committee unveils the Clarity …
The message is deliberate. This is not just politics. American bigBusinessis in the room — and it wants a deal.
Nvidia (Nasdaq:NVDA) CEO Jensen Huang joins Trump's Beijing summit after a last-minute presidential call, putting semiconductor export controls and H200 chip access on the live negotiating agenda with Xi Jinping for the first time.Key HighlightsA personal call from Trump brought Huang onto Air Force …
Please wait processing your request...